Clinical Trial Update: Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting [Phase 4]

View source ↗

Summary

Phase IV trial evaluating the safety of self-administered ADASUVE in agitated patients outside the hospital setting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation

Drugs mentioned

• Adasuve (loxapine)

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Agitation | Phase 4 | Status: COMPLETED